The mutation-dependent pathogenicity ofNPHS2p.R229Q: A guide for clinical assessment
Authors:
- 22 October 2018
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 39 (12) , 1854-1860
Abstract
NPHS2, encoding podocin, is the major gene implicated in steroid‐resistant nephrotic syndrome. Its c.686G>A, p.R229Q variant is the first human variant with a mutation‐dependent pathogenicity: it is only pathogenic when trans‐associated to specific mutations. Secondary to its high allele frequency in the European, South Asian, African and Latino populations, its benign trans‐associations can be accidentally identified in affected patients. Distinguishing pathogenic and benign p.R229Q‐associations can be challenging. In this paper, we present the currently known pathogenic and benign associations, and show that a rare p.R229Q‐association can be considered pathogenic if the variant in trans meets the following criteria: it affects the 270–351 residues and alters but does not disrupt the oligomerization, its p.R229Q‐association is found in a family with slowly progressing focal segmental glomerulosclerosis, but is expected to be rare in the general population (15% of the p.R229Q associations identified so far in patients are benign. This article is protected by copyright. All rights reservedKeywords
Funding Information
- Emberi Eroforrások Minisztériuma
- Seventh Framework Programme (2012-305608)
- Magyar Tudományos Akadémia (MTA-SE Lendulet Research Grant (LP2015-11/2015), MedinProt Synergy Grant (DKM, KT))
- Nemzeti Kutatási és Technológiai Hivatal (K109718, K116305, KH125566, EFOP-3.6.3-EKOP-16-2017-00009)
- Agence Nationale de la Recherche (ANR-10-IAHU-01, ANR-12-BSV1-0033.01)
This publication has 27 references indexed in Scilit:
- NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosisPediatric Nephrology, 2013
- Screening for NPHS2 Mutations May Help Predict FSGS Recurrence after TransplantationJournal of the American Society of Nephrology, 2011
- Clinical Value of NPHS2 Analysis in Early- and Adult-Onset Steroid-Resistant Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2011
- Immunosuppression and Renal Outcome in Congenital and Pediatric Steroid-Resistant Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2010
- Adequate use of allele frequencies in Hispanics—a problem elucidated in nephrotic syndromePediatric Nephrology, 2010
- NPHS2variation in focal and segmental glomerulosclerosisBMC Nephrology, 2008
- NPHS2 screening with SURVEYOR in Hellenic children with steroid-resistant nephrotic syndromePediatric Nephrology, 2008
- Specific Podocin Mutations Correlate with Age of Onset in Steroid-Resistant Nephrotic SyndromeJournal of the American Society of Nephrology, 2008
- NPHS2 (podicin) mutations in Turkish children with idiopathic nephrotic syndromePediatric Nephrology, 2007
- Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic SyndromeJournal of the American Society of Nephrology, 2004